Found: 17
Select item for more details and to access through your institution.
Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1085940
- By:
- Publication type:
- Article
SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1082191
- By:
- Publication type:
- Article
Advances in immunotherapy for glioblastoma multiforme.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.944452
- By:
- Publication type:
- Article
Alveolar macrophage metabolic programming via a C-type lectin receptor protects against lipo-toxicity and cell death.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34935-w
- By:
- Publication type:
- Article
Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 2, p. 1, doi. 10.1371/journal.ppat.1005446
- By:
- Publication type:
- Article
The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08390-z
- By:
- Publication type:
- Article
Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61736-2
- By:
- Publication type:
- Article
Licensed and Unlicensed NK Cells: Differential Roles in Cancer and viral Control.
- Published in:
- Frontiers in Immunology, 2016, p. 1, doi. 10.3389/fimmu.2016.00166
- By:
- Publication type:
- Article
Mouth rinses efficacy on salivary SARS‐CoV‐2 viral load: A randomized clinical trial.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28412
- By:
- Publication type:
- Article
Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies.
- Published in:
- Pathogens, 2020, v. 9, n. 12, p. 1067, doi. 10.3390/pathogens9121067
- By:
- Publication type:
- Article
The role of Aquaporins in tumorigenesis: implications for therapeutic development.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-023-01459-9
- By:
- Publication type:
- Article
The role of Aquaporins in tumorigenesis: implications for therapeutic development.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-023-01459-9
- By:
- Publication type:
- Article
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-73491-5
- By:
- Publication type:
- Article
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1350208
- By:
- Publication type:
- Article
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.
- Published in:
- Frontiers in Immunology, 2020, p. N.PAG, doi. 10.3389/fimmu.2020.01986
- By:
- Publication type:
- Article
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 7, p. 1413, doi. 10.3390/v13071413
- By:
- Publication type:
- Article